UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of clinical oncology, ISSN 0732-183X, 07/2017, Volume 35, Issue 20, pp. 2260 - 2267
Life Sciences & Biomedicine | Oncology | Science & Technology | Doxorubicin - therapeutic use | Recurrence | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Transplantation, Autologous | Methotrexate - therapeutic use | Lymphoma, B-Cell - genetics | Cyclophosphamide - therapeutic use | Stem Cell Transplantation | Female | Ifosfamide - therapeutic use | Etoposide - therapeutic use | Survival Rate | Remission Induction | Cytarabine - administration & dosage | Proto-Oncogene Proteins c-bcl-6 - genetics | Disease-Free Survival | Dexamethasone - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Methotrexate - administration & dosage | Proto-Oncogene Proteins c-myc - genetics | Proto-Oncogene Proteins c-bcl-2 - genetics | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Index Medicus | ORIGINAL REPORTS
Journal Article
Paediatric drugs, ISSN 1174-5878, 2010, Volume 12, Issue 2, pp. 85 - 98
Journal Article
Blood, ISSN 0006-4971, 11/2014, Volume 124, Issue 19, pp. 2913 - 2920
Life Sciences & Biomedicine | Hematology | Science & Technology | Doxorubicin - therapeutic use | Nasopharyngeal Neoplasms - genetics | Translocation, Genetic | Ifosfamide - therapeutic use | Prognosis | Cytarabine - therapeutic use | Humans | Etoposide - therapeutic use | Male | Burkitt Lymphoma - diagnosis | Methotrexate - therapeutic use | Cyclophosphamide - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Burkitt Lymphoma - genetics | Adult | Nasopharyngeal Neoplasms - drug therapy | Nasopharyngeal Neoplasms - diagnosis | Prednisone - therapeutic use | Burkitt Lymphoma - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Haematologica (Roma), ISSN 0390-6078, 2017, Volume 102, Issue 2, pp. 356 - 363
Life Sciences & Biomedicine | Hematology | Science & Technology | Doxorubicin - therapeutic use | Cytarabine - therapeutic use | Humans | Middle Aged | Podophyllotoxin - therapeutic use | Male | Melphalan - therapeutic use | Cyclophosphamide - therapeutic use | Young Adult | Carmustine - therapeutic use | Lymphoma, Large B-Cell, Diffuse - diagnostic imaging | Lymphoma, Large B-Cell, Diffuse - therapy | Adult | Female | Carboplatin - administration & dosage | Etoposide - administration & dosage | Treatment Outcome | Positron-Emission Tomography - methods | Lymphoma, Large B-Cell, Diffuse - mortality | Rituximab - administration & dosage | Retreatment | Ifosfamide - administration & dosage | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Fluorodeoxyglucose F18 | Aged | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 02/2016, Volume 122, Issue 4, pp. 559 - 564
BCL6 (B‐cell lymphoma 6) | non‐Hodgkin lymphoma | gene rearrangement | BCL2 (B‐cell lymphoma 2) | MYC | BCL6 (B-cell lymphoma 6) | non-Hodgkin lymphoma | BCL2 (B-cell lymphoma 2) | Life Sciences & Biomedicine | Oncology | Science & Technology | Doxorubicin - therapeutic use | Prognosis | Cytarabine - therapeutic use | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Bone Marrow Neoplasms - genetics | Lymphoma, B-Cell - genetics | Cyclophosphamide - therapeutic use | Lymphoma, Non-Hodgkin - pathology | Burkitt Lymphoma - pathology | Burkitt Lymphoma - genetics | Female | Burkitt Lymphoma - drug therapy | Databases, Factual | Lymphoma, B-Cell - drug therapy | Lymphoma, Non-Hodgkin - drug therapy | Ifosfamide - therapeutic use | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Central Nervous System Neoplasms - genetics | Etoposide - therapeutic use | Survival Rate | Germinal Center - pathology | Lymphoma, Non-Hodgkin - genetics | DNA-Binding Proteins - genetics | Genes, bcl-2 - genetics | Rituximab - administration & dosage | Central Nervous System Neoplasms - pathology | Dexamethasone - therapeutic use | Bone Marrow Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Gene Rearrangement | Genes, myc - genetics | Lymphoma, B-Cell - pathology | Vincristine - therapeutic use | Bone Marrow Neoplasms - drug therapy | Central Nervous System Neoplasms - drug therapy | Lymphoma, Large B-Cell, Diffuse - genetics | Prednisone - therapeutic use | Cohort Studies | Proto-Oncogene Proteins c-bcl-6 | Care and treatment | Chemotherapy | Usage | Non-Hodgkin's lymphomas | Diagnosis | Research | Oncogenes | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
American journal of clinical oncology, ISSN 0277-3732, 02/2015, Volume 38, Issue 1, pp. 68 - 73
chemoradiotherapy | autologous stem cell transplantation | Hodgkin lymphoma | Life Sciences & Biomedicine | Oncology | Science & Technology | Doxorubicin - therapeutic use | Methylprednisolone - therapeutic use | Cytarabine - therapeutic use | Dacarbazine - therapeutic use | Hodgkin Disease - pathology | Humans | Middle Aged | Male | Transplantation, Autologous | Melphalan - therapeutic use | Vinblastine - therapeutic use | Neoplasm Recurrence, Local - pathology | Young Adult | Carmustine - therapeutic use | Bleomycin - therapeutic use | Carboplatin - therapeutic use | Mediastinal Neoplasms - therapy | Adult | Female | Retrospective Studies | Chemoradiotherapy - methods | Ifosfamide - therapeutic use | Neoplasm Recurrence, Local - therapy | Etoposide - therapeutic use | Treatment Outcome | Dexamethasone - therapeutic use | Stem Cell Transplantation - methods | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - pathology | Hodgkin Disease - therapy | Adolescent | Neoplasm Staging | Cohort Studies | Index Medicus
Journal Article
Annals of oncology, ISSN 0923-7534, 05/2011, Volume 22, Issue 5, pp. 1221 - 1227
chemotherapy-induced necrosis | Ewing sarcoma | high-dose chemotherapy | Chemotherapy-induced necrosis | High-dose chemotherapy | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Diseases of the osteoarticular system | Tumors of striated muscle and skeleton | Myeloablative Agonists - therapeutic use | Bone Neoplasms - mortality | Doxorubicin - therapeutic use | Bone Neoplasms - therapy | Sarcoma, Ewing - therapy | Humans | Child, Preschool | Male | Sarcoma, Ewing - mortality | Melphalan - therapeutic use | Cyclophosphamide - therapeutic use | Young Adult | Dactinomycin - therapeutic use | Adult | Female | Child | Ifosfamide - therapeutic use | Busulfan - therapeutic use | Kaplan-Meier Estimate | Etoposide - therapeutic use | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Vincristine - therapeutic use | Peripheral Blood Stem Cell Transplantation | Index Medicus | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Cancer and Oncology | Cancer och onkologi
Journal Article
Asian Pacific journal of cancer prevention : APJCP, ISSN 1513-7368, 2014, Volume 15, Issue 9, pp. 3951 - 3954
Nausea/vomitting | Chemotherapy | Electronic anti-nausea instrument | Palonosetron | Life Sciences & Biomedicine | Oncology | Science & Technology | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Antineoplastic Agents - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Carmustine - therapeutic use | Quinuclidines - therapeutic use | Antineoplastic Agents - adverse effects | Nausea - therapy | Antiemetics - therapeutic use | Adult | Vomiting - prevention & control | Carmustine - adverse effects | Ifosfamide - therapeutic use | Ifosfamide - adverse effects | Serotonin Antagonists - therapeutic use | Neoplasms - drug therapy | Nausea - prevention & control | Serotonin 5-HT3 Receptor Antagonists - therapeutic use | Cisplatin - therapeutic use | Electric Stimulation Therapy - methods | Cisplatin - adverse effects | Epirubicin - therapeutic use | Isoquinolines - therapeutic use | Aged | Vomiting - therapy | Doxorubicin - adverse effects | Epirubicin - adverse effects
Journal Article
Blood, ISSN 0006-4971, 07/2015, Volume 126, Issue 2, pp. 160 - 166
Life Sciences & Biomedicine | Hematology | Science & Technology | HIV-1 | Doxorubicin - therapeutic use | Cytarabine - therapeutic use | HIV Infections - epidemiology | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cytarabine - adverse effects | Methotrexate - therapeutic use | Cyclophosphamide - adverse effects | Burkitt Lymphoma - epidemiology | Cyclophosphamide - therapeutic use | Young Adult | Adult | Female | Burkitt Lymphoma - drug therapy | Ifosfamide - therapeutic use | Etoposide - adverse effects | Ifosfamide - adverse effects | Rituximab | Etoposide - therapeutic use | Treatment Outcome | Burkitt Lymphoma - etiology | Antiretroviral Therapy, Highly Active | Methotrexate - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | HIV Infections - complications | Vincristine - therapeutic use | Vincristine - adverse effects | HIV Infections - drug therapy | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Index Medicus | Abridged Index Medicus | Clinical Trials and Observations
Journal Article
Annals of oncology, ISSN 0923-7534, 11/2012, Volume 23, Issue 11, pp. 2970 - 2976
total-lung irradiation | lung metastases | Ewing's sarcoma | high-dose chemotherapy | Lung metastases | Total-lung irradiation | High-dose chemotherapy | Life Sciences & Biomedicine | Oncology | Science & Technology | Pharmacology. Drug treatments | Diseases of the osteoarticular system | Tumors of striated muscle and skeleton | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pneumology | Myeloablative Agonists - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Bone Neoplasms - therapy | Sarcoma, Ewing - therapy | Humans | Bone Neoplasms - secondary | Child, Preschool | Lung Neoplasms - radiotherapy | Male | Antineoplastic Agents - therapeutic use | Melphalan - therapeutic use | Cyclophosphamide - therapeutic use | Stem Cell Transplantation | Young Adult | Lung Neoplasms - secondary | Neoplasm Metastasis - drug therapy | Adult | Female | Child | Ifosfamide - therapeutic use | Busulfan - therapeutic use | Neoplasm Metastasis - radiotherapy | Etoposide - therapeutic use | Combined Modality Therapy | Lung Neoplasms - therapy | Sarcoma, Ewing - drug therapy | Sarcoma, Ewing - secondary | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Vincristine - therapeutic use | Sarcoma, Ewing - radiotherapy | Index Medicus | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | total-lung | Klinisk medicin | Cancer and Oncology | irradiation | Cancer och onkologi
Journal Article
Annals of oncology, ISSN 0923-7534, 09/2014, Volume 25, Issue 9, pp. 1775 - 1782
germ-cell tumors | hematopoietic stem-cell transplantation | nonrefractory patients | TAXIF II trial | high-dose chemotherapy | Nonrefractory patients | Germ-cell tumors | High-dose chemotherapy | Hematopoietic stem-cell transplantation | Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Thiotepa - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - therapeutic use | Carboplatin - adverse effects | Young Adult | Carboplatin - therapeutic use | Antineoplastic Agents - adverse effects | Treatment Failure | Adult | Female | Neoplasms, Germ Cell and Embryonal - drug therapy | Neoplasms, Germ Cell and Embryonal - mortality | Ifosfamide - therapeutic use | Etoposide - adverse effects | Ifosfamide - adverse effects | Hematopoietic Stem Cell Transplantation | Paclitaxel - adverse effects | Etoposide - therapeutic use | Paclitaxel - therapeutic use | Disease-Free Survival | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Cisplatin - adverse effects | Epirubicin - therapeutic use | Neoplasms, Germ Cell and Embryonal - surgery | Epirubicin - adverse effects | Thiotepa - adverse effects | Index Medicus
Journal Article